Attovia Therapeutics, Inc. Common Stock (ATTO)

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Attovia Therapeutics, Inc. Common Stock (ATTO) is listed on Nasdaq, where it has traded since August 5, 2026.

Listed On
Nasdaq
Listed Since
August 5, 2026
Market Cap
$723M

About Attovia Therapeutics, Inc. Common Stock

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Institutional ownership

In 13F filings for the quarter ended June 30, 2025, 1 institution reported holding ATTO, with 9,438 shares worth $98,626 in aggregate. The largest reported holder was Northwest & Ethical Investments, with 9,438 shares worth $98,626. Of the 1 largest holders listed below, 1 opened a new position in ATTO during the quarter.

InstitutionSharesValueQuarter change
Northwest & Ethical Investments9,438$99KNew position

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is ATTO?

Attovia Therapeutics, Inc. Common Stock (ATTO) is listed on Nasdaq, where it has traded since August 5, 2026.

Who are the largest institutional holders of ATTO?

In 13F filings for the quarter ended June 30, 2025, the largest reported holders of ATTO were Northwest & Ethical Investments.

How many institutions own ATTO?

1 institution reported a position in ATTO for the quarter ended June 30, 2025, worth $98,626 in total.

Did institutions buy or sell ATTO last quarter?

Of the 1 largest reported holders, 1 opened a new position in ATTO during the quarter. Every reported holder and its change is on the SentiSense ownership page for ATTO.

Every reported institutional holder, plus insider and congressional trades in ATTO, on SentiSense.